Remove Drug Trials Remove Life Science Remove Trials
article thumbnail

Scaling With a Purpose: Championing the Clinical Trials Sector

Velocity Clinical Research

For a clinical trials organization to achieve this level of scale is notable. The clinical trials sector in the US is typically made up of small independent businesses that collectively play an important role in trialing new protocols and aiding drug development. Velocity is among the few exceptions.

article thumbnail

Diseases Don’t Discriminate, So Why Aren’t Clinical Trials More Diverse?

XTalks

Expanding minority Americans’ access to care and clinical trials isn’t just the right thing to do. Clinical Trials Don’t Reflect Demographics. Disease doesn’t discriminate, and researchers understand different populations react differently to drugs. Why, then, are clinical trials so stubbornly homogeneous?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Clinical Trials for Pulmonary Fibrosis: How Can Participation Be Improved?

XTalks

Clinical trials for pulmonary fibrosis are being conducted to evaluate the effectiveness of novel therapies and interventions, providing hope for improved outcomes in the future. They aim to improve patient outcomes, slow disease progression and enhance quality of life.

article thumbnail

Diversity in Clinical Trials: Tackling the Issues in Alzheimer’s Research at AAIC 2021

XTalks

Just as clinical researchers in other therapeutic areas have renewed their commitment to improving participant diversity in clinical trials, so too have those working in Alzheimer’s research. What Factors Promote Alzheimer’s Clinical Trial Participation? Similarly, older Latino and Hispanic individuals are 1.5

article thumbnail

FDA Approvals for a Liquid Epilepsy Drug and Vitiligo Medication – Xtalks Life Science Podcast Ep. 71

XTalks

Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Opzelura Vitiligo Med Wins FDA Approval as First Treatment for Repigmentation. The weekly podcast is available for streaming every Wednesday on Spotify , Apple Music and wherever you stream your podcasts.

article thumbnail

Steps to building a more patient-centric industry

pharmaphorum

Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found that patients felt clinical trial participation to be inconvenient and burdensome, and nearly half (49.0%) said it disrupted their daily routine.

article thumbnail

Building Inclusive Trials: Insights from CTTI’s Diversity Initiatives

XTalks

Diverse clinical trials are a matter of equity and essential for the validity and reliability of research outcomes. Historically, racial and ethnically minoritized groups or populations have been excluded from clinical trials, leading to a lack of data on how different demographic subgroups respond to treatments.

Trials 52